oral tirzepatide development status Beyond glycemia: Comparing to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders Oral Tirzepatide: What the Research

Unlike hGH, which can cause rapid changes in body composition and potential adverse effects, this alternative fosters gradual improvements that align with your bodys natural processes

Studies administering 3 gm/day to 6 gm thrice daily over 1 to 24 months reported significant improvements, corroborated by recent trials with doses up to 2 gm/day without adverse effects

For many patients, weekly injections are generally considered the more traditional and evidence-supported route for GLP-1 weight management

It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists , which work by mimicking the action of a naturally occurring hormone that regulates blood glucose levels and appetite

These include nausea, diarrhoea, abdominal pain, and metallic taste, affecting up to 30% of patients, particularly when treatment is initiated or doses increased

Fonseca M, Carmo F, Martel F